Impact News +++ Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN) +++ GERON Aktie +3,94%

Gewinn & Umsatz News zur KENVUE Aktie

>KENVUE Aktienkurs

15.884 EUR +2.2% (TradegateBSX)

Ask: 16.084 EUR / 300 Stück

Bid: 15.918 EUR / 300 Stück

Tagesumsatz: 986 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

KENVUE Aktie über LYNX handeln

Intraday

1 Jahr

>KENVUE Performance

1 Woche: +1,2%

1 Monat: +5,5%

3 Monate: +10,8%

6 Monate: -14,5%

1 Jahr: -26,5%

laufendes Jahr: +6,1%

>KENVUE Aktie

Name:

KENVUE INC. DL -,001

Land:

USA

Sektor:

Konsumgueter / Gastronomie

ISIN/ Wkn:

US49177J1025 / A3EEHU

Symbol/ Ticker:

J4D (Frankfurt) / KVUE (NYSE)

Kürzel:

FRA:J4D, ETR:J4D, J4D:GR, NYSE:KVUE

Index:

Webseite:

https://www.kenvue.com/

Profil:

Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-ro..
>Volltext..

Marktkapitalisierung:

30281.92 Mio. EUR

Unternehmenswert:

37083.99 Mio. EUR

Umsatz:

12681.76 Mio. EUR

EBITDA:

2787.37 Mio. EUR

Nettogewinn:

1211.13 Mio. EUR

Gewinn je Aktie:

0.63 EUR

Schulden:

7698.65 Mio. EUR

Liquide Mittel:

962.65 Mio. EUR

Operativer Cashflow:

1805.28 Mio. EUR

Bargeldquote:

0.19

Umsatzwachstum:

-7.9%

Gewinnwachstum:

27.79%

Dividende je Aktie:

0.71 EUR

Dividendenrendite:

4.41%

Dividendenschätzung:

4.44%

Div. Historie:

11.02.26 - 0.17432074€
12.11.25 - 0.17892724€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

KENVUE

Letzte Datenerhebung:

18.02.26

>KENVUE Kennzahlen

Aktien/ Unternehmen:

Aktien: 1916.01 Mio. St.

Frei handelbar: 99.94%

Leerverk. Aktien: 2.74%

Rückkaufquote: 0.89%

Mitarbeiter: 22000

Umsatz/Mitarb.: 0.59 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 0.43%

Bewertung:

KGV: 24.73

KGV lG: 17.86

KUV: 2.36

KBV: 3.31

PEG-Ratio: 0.72

EV/EBITDA: 13.3

Rentabilität:

Bruttomarge: 58.21%

Gewinnmarge: 9.55%

Operative Marge: 18.2%

Managementeffizenz:

Gesamtkaprendite: 5.29%

Eigenkaprendite: 13.47%

>KENVUE Peer Group

Konsumgueter / Gastronomie

>KENVUE Chart & Kurs - NYSE

>KENVUE Gewinn & Umsatz News

17.02.26 - 23:48	Kenvue Inc. Profit Climbs In Q4 (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) announced earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at $330 million, or $0.17 per sh......

27.01.26 - 12:42	Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote (WSJ EN)
	Kimberly-Clark reported a higher profit in its latest quarter just days before shareholders vote on its plan to buy Kenvue, a deal designed to create a global health-and-wellness giant....

03.11.25 - 15:30	Kenvue Q3 EPS Beats, Confirms FY25 Outlook, Appoints Kirk Perry As CEO; Stock Up (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE), a global consumer health company, Monday reported an increase in profit for the third quarter, compared to the last year. On an adjusted basis, earnings ......

03.11.25 - 13:09	Kenvue jumps 22% on $48.7 billion Kimberly-Clark merger deal, reports Q3 earnings (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.25 - 13:01	Kenvue Inc. Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) reported earnings for its third quarter that Increased from last year and beat the Street estimates.The company's bottom line came in at $398 million, or ......

03.10.25 - 21:36	Operative Herausforderungen: Moody′s stuft Kenvue-Ausblick auf "negativ" herab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 14:48	Kenvue Cuts Outlook on Weak Demand as Brand Review Continues (Bloomberg)
	Kenvue Inc. slashed its full-year sales target as demand continued to deteriorate and the company searches for a new chief executive officer to help reset the business....

07.08.25 - 14:48	ROUNDUP: Kenvue Q2 Profit Beats Market, Sales Miss; Cuts FY25 Outlook (AFX)
	WASHINGTON (dpa-AFX) - Consumer health company Kenvue, Inc. (KVUE), while reporting second-quarter profit above market estimates and net sales below the Street, on Thursday trimmed its fiscal 2025......

07.08.25 - 13:48	Kenvue Inc. Announces Advance In Q2 Profit (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) revealed a profit for its second quarter that Increases, from last yearThe company's bottom line totaled $420 million, or $0.22 per share. This compares w......

07.08.25 - 13:09	Kenvue shares fall as Q2 results miss estimates, company cuts guidance (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.25 - 10:30	Kenvue Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Kenvue has outpaced the broader market over the past year, and analysts remain cautiously optimistic about the stock's prospects....

16.07.25 - 19:36	Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing (Barchart)
	Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually......

16.07.25 - 13:42	Kenvues Q2 2025 Earnings: What to Expect (Barchart)
	Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip....

08.05.25 - 15:24	Kenvue Boosts 2025 Sales Growth View (WSJ EN)
	The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, while warning that foreign exchange would weigh on adjusted earnings....

08.05.25 - 14:16	Kenvue first-quarter results beat estimates helped by strong demand for self care products (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.25 - 13:42	ROUNDUP: Kenvue Boosts FY25 Net Sales Outlook: Appoints Amit Banati To Succeed Paul Ruh As CFO (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Thursday, consumer health company Kenvue, Inc. (KVUE) boosts net sales growth guidance for the full-year 2025. Adj......

08.05.25 - 13:18	Kenvue Inc. Q1 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) announced a profit for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled $32......

08.05.25 - 13:12	Kenvue′s Q2 earnings, revenue beat expectations (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

23.04.25 - 10:06	Kenvue Earnings Preview: What to Expect (Barchart)
	Kenvue is set to unveil its Q1 results in the upcoming month, and analysts expect a notable decline in earnings....

06.02.25 - 14:30	ROUNDUP: Kenvue Q4 Profit Meets Market; Sees FY25 Adj. EPS In Line Or Above Last Year (AFX)
	WASHINGTON (dpa-AFX) - Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday issued fiscal 2025 outlook. In the pre-ma......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Von allen Gütern ist das beste, ein edles Weib zu haben. - Euripides

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram